Already a member? Sign in
Category: Prescription Drugs
Most Popular Types: Artane, Benzhexol, Trihexyphen (Show all)
Generic Name: Trihexyphenidyl
Trihexyphenidyl is anti-Parkinson's and anticholinergic agent used as adjunctive treatment of Parkinson's disease and for the treatment of drug-induced extrapyramidal symptoms.
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| Parkinson's Disease | 57 | 17 |
|
|
|
|
|
| Tremor in hands | 20 | 9 |
|
|
|
|
|
| Tremor | 10 | 2 |
|
||||
| Other | 6 | 1 |
|
||||
| Dystonia | 3 | 2 |
|
|
|||
| Increase effect of another treatment | 2 | 2 |
|
|
See all 96 patients currently taking Trihexyphenidyl
Mouse over the table for more information
Commonly reported side effects, conditions, and hospitalizations associated with Trihexyphenidyl
| Cognitive Confusion | 9 | |
|---|---|---|
| Word fishing | 6 | |
| Sleep problems | 4 | |
| Dry mouth (xerostomia) | 3 | |
| Sleepiness | 3 | |
| Short temper | 2 | |
| See all 23 reported side effects ▼ | ||
Frequently reported dosages based on patients currently taking Trihexyphenidyl. See all 22 dosages ►
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Side effects too severe | 15 | ||
| Doctor's advice | 14 | ||
| Did not seem to work | 11 | ||
| Other | 4 | ||
| Personal research | 2 | ||
| Expense | 1 |
Adherence
Taking treatment as prescribed
Adherence of Trihexyphenidyl
Always |
22 | 61% |
|
|---|---|---|---|
Usually |
12 | 33% |
|
Sometimes |
1 | 3% |
|
Never |
1 | 3% |
|
Burden
Difficulty being on treatment
Burden of Trihexyphenidyl
Very |
2 | 6% |
|
|---|---|---|---|
Somewhat |
2 | 6% |
|
A little |
10 | 28% |
|
Not at all |
22 | 61% |
|
Cost
Paid out of pocket
Cost of Trihexyphenidyl
$200+ |
0 | 0% |
|
|---|---|---|---|
$100-199 |
0 | 0% |
|
$50-99 |
0 | 0% |
|
$25-49 |
1 | 4% |
|
< $25 |
24 | 96% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on May 28, 2012.